These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 24291019

  • 1. Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
    Carvalheiro J, Mendes S, Sofia C.
    J Crohns Colitis; 2014 May; 8(5):436-7. PubMed ID: 24291019
    [No Abstract] [Full Text] [Related]

  • 2. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
    Puli SR, Benage DD.
    Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
    [No Abstract] [Full Text] [Related]

  • 3. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M.
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract] [Full Text] [Related]

  • 4. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS, Saad A, Bortman JS, Amin M.
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract] [Full Text] [Related]

  • 5. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Infliximab as first-line therapy for Crohn's disease is premature.
    Greenberg GR.
    Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab as first-line therapy for severe Crohn's disease?
    Cohen RD.
    Inflamm Bowel Dis; 2002 Jan; 8(1):58-9; discussion 63-5. PubMed ID: 11837940
    [No Abstract] [Full Text] [Related]

  • 9. Interstitial pneumonitis after infliximab therapy for Crohn's disease.
    Weatherhead M, Masson S, Bourke SJ, Gunn MC, Burns GP.
    Inflamm Bowel Dis; 2006 May; 12(5):427-8. PubMed ID: 16670533
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S.
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV.
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR.
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract] [Full Text] [Related]

  • 18. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection.
    Campbell S, Ghosh S.
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):191-2. PubMed ID: 11246620
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.